LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer
Measuring LSD1+8a mRNA is a sensitive and specific method for the diagnosis of NEPC, which is often challenging.
Authors
- Hui Li (ORCID: https://orcid.org/0000-0001-7145-4681)
- Colm M. Morrissey (ORCID: https://orcid.org/0000-0003-1906-5333)
- Eva Corey (ORCID: https://orcid.org/0000-0002-9244-3807)
- Eva S. Rodansky
- Joshi J. Alumkal (ORCID: https://orcid.org/0000-0003-1278-0166)
- Rahul Mannan (ORCID: https://orcid.org/0000-0002-6642-0468)
- Michael Haffner (ORCID: https://orcid.org/0000-0001-9906-6832)
- Joel A. Yates (ORCID: https://orcid.org/0000-0002-1462-8494)
- Anbarasu Kumaraswamy (ORCID: https://orcid.org/0000-0002-9997-7430)
- Peter S. Nelson (ORCID: https://orcid.org/0000-0002-5451-5726)
- Aaron M. Udager (ORCID: https://orcid.org/0000-0002-8254-5404)
- Olivia A Swaim (ORCID: https://orcid.org/0009-0004-8573-5440)
- Xiaoming Wang (ORCID: https://orcid.org/0000-0002-9671-6358)
- Rohit Mehra
- Arul M. Chinnaiyan
Institutions
- University of Washington (US)
- University of Michigan (US)
- Fred Hutch Cancer Center (US)
- Michigan Medicine (US)
- Michigan Center for Translational Pathology (US)
- Aptose Biosciences (United States) (US)
Publication Details
- Journal
- Neoplasia
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1016/j.neo.2025.101151
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52